Replies to post #4741 on SiNtx Technologies Inc (SINT)

[Dough Theory]

I think we will hear on a partnership deal soon,imo.

The FDA approval is going to take some time, I was told the clock has stopped until the company responds to the FDA and at that time they will put out a news release.

[Atlanta1]

all I care about is that they are selling at a market cap of less than 1x their current revenue run rate, with a pipeline of new products ahead.

$AMDA

[boston745]

Series C warrants are done, finished last year. Series A are still out there with a max os of 12.2mil not including their new deal with riverside

Do the math, they do not need to dilute. The deal with riverside did two things, saved them from paying principle (~500k) & dropped their coh requirement to 6.5mil. This will carry them till May where they can elect to have Riverside pick upto 2 mil more principle debt. This would drop the COH requirement to 5.5mil. All of this though was done to bide them time until they can refinance; which I assume is in the works based on the recent PR.

Riverside warrants are not exercisable for 6 months and the principle note does not convert until 2018 if Amedica doesn't pay them instead.
For now, no new dilution. Expect more warrants with any new loan and hopefully the terms will give them access to their current cash on hand.